SCHEMBL1490434

SCHEMBL1490434

COc1cc(F)c(C(=O)Nc2csc(-c3cccc(I)c3)c2C(=O)O)c(F)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.39
▸ MEN1 O00255 6/20 0.38
▸ KMT2A Q03164 6/20 0.38
▸ DHODH Q02127 4/20 0.38
▸ PKM P14618 1/20 0.37
▸ ABCB1 P08183 3/20 0.37
▸ LMNA P02545 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ ABCC1 P33527 1/20 0.36
▸ IL2 P60568 1/20 0.36
▸ MAPT P10636 1/20 0.35
▸ ACLY P53396 1/20 0.35
▸ JMJD7 P0C870 1/20 0.34
▸ NR4A1 P22736 1/20 0.34
▸ NR4A2 P43354 1/20 0.34
▸ NR4A3 Q92570 1/20 0.34
▸ NR1H4 Q96RI1 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ ANO1 Q5XXA6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1490292 0.91 POLB (0.40) POLBMEN1KMT2ADHODHPKM
SCHEMBL1490548 0.90 KMT2A (0.39) POLBMEN1KMT2ADHODHPKM
SCHEMBL1490555 0.90 DHODH (0.48) POLBMEN1KMT2ADHODHABCB1
SCHEMBL1490423 0.90 PTGFR (0.40) POLBMEN1KMT2ADHODHPKM
SCHEMBL1490343 0.90 POLB (0.43) POLBMEN1KMT2ADHODHPKM
SCHEMBL1490424 0.89 LMNA (0.38) POLBMEN1KMT2ADHODHPKM
SCHEMBL1490335 0.89 DHODH (0.38) POLBMEN1KMT2ADHODHPKM
SCHEMBL1490475 0.86 TP53 (0.39) POLBMEN1KMT2AABCB1LMNA
SCHEMBL1490357 0.85 MEN1 (0.44) POLBMEN1KMT2ADHODHABCB1
SCHEMBL1490427 0.85 MEN1 (0.44) POLBMEN1KMT2AABCB1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 — — US disclosed
US-8618307-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-12-31 — — US disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 POLB 4774/4885MEN1 2958/4885KMT2A 4706/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 POLB 4774/4885MEN1 2958/4885KMT2A 4706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback